ChristianaCare, a nationally recognized leader in healthcare, is actively recruiting a Medical Director, Center for Medical Genetics and Genomics at its Helen F. Graham Cancer Center & Research Institute

Fellowship trained Medical Geneticists are encouraged to apply!

Why ChristianaCare?

• Join Delaware's premier health system and an established program that provides next generation genetic services in cancer, pre-natal, cardiovascular, neurology, adult, and autism care
• Work with a unique and diverse patient population while serving as a strategic decision-maker with regards to population health initiatives
• Take advantage of robust team support that includes a Clinical Director, 9 genetic counselors, 3 genetic assistants, 4 access coordinators, and a Practice Supervisor
• Provide direct patient care and assist with inpatient consults
• Enjoy a Monday-Friday work schedule with no call
• Choose to live in Maryland, Delaware, Pennsylvania, or New Jersey
• President/CEO Dr. Janice Nevin named among 50 Most Influential Clinical Executives in 2023 By Modern Healthcare

Compensation & benefits package include:

• Base salary, bonus incentive, Public Service Loan Forgiveness (PSLF) eligibility, plus sign-on & relocation bonus
• Health, dental and vision benefits
• Generous Time Away from Practice (TAP) program for CME, planned and unplanned time off
• 403b, 457b, and Defined Contribution Plans
• Fully paid malpractice insurance
• 12 weeks paid parental leave

Requirements:

• MD degree with board certification in Medical Genetics
• Demonstrated clinical experience in medical genetics along with ambition to grow and expand program

About the Helen F. Graham Cancer Center & Research Institute
The Helen F. Graham Cancer Center & Research Institute, a National Cancer Institute Community Oncology Research Program, is part of the ChristianaCare, one of the country's most dynamic health systems, centered on improving health outcomes, making high-quality care more accessible and lowering health care costs. With more than 245,000 patient visits last year, the Graham Cancer Center is recognized as a national model for multidisciplinary cancer care and a top enroller in U.S. clinical research trials. In conjunction with the Gene Editing Institute, the Center for Translational Cancer Research, the Tissue Procurement Center, statewide High-Risk Family Cancer Registry and collaborations with world-renowned scientists at facilities such as The Wistar Institute in Philadelphia scientists are opening new avenues to more quickly translate cancer science into cancer medicine. For more information, visit christianacare.org/cancer.

About ChristianaCare:

Headquartered in Wilmington, Delaware, ChristianaCare is one of the country's most dynamic health care organizations, centered on improving health outcomes, making high-quality care more accessible and lowering health care costs.

ChristianaCare includes an extensive network of primary care and outpatient services, home health care, urgent care centers, three hospitals (1,336 beds), a freestanding emergency department, a Level I trauma center and a Level III neonatal intensive care unit, a comprehensive stroke center and regional centers of excellence in heart and vascular care, cancer care and women's health. It also includes the pioneering Gene Editing Institute.

ChristianaCare is nationally recognized as a great place to work, rated by Forbes as the 2nd best health system for diversity and inclusion, and the 29th best health system to work for in the United States, and by IDG Computerworld as one of the nation's Best Places to Work in IT. ChristianaCare is rated by Healthgrades as one of America's 50 Best Hospitals and continually ranked among the nation's best by U.S. News & World Report, Newsweek and other national quality ratings. ChristianaCare is a nonprofit teaching health system with more than 260 residents and fellows. With its groundbreaking Center for Virtual Health and a focus on population health and value-based care, ChristianaCare is shaping the future of health care.